ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P28907


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name CD38_HUMAN
Primary accession number P28907
Secondary accession numbers O00121 O00122 Q96HY4
Integrated into Swiss-Prot on December 1, 1992
Sequence was last modified on November 23, 2004 (Sequence version 2)
Annotations were last modified on    November 25, 2008 (Entry version 94)
Name and origin of the protein
Protein name ADP-ribosyl cyclase 1
Synonyms EC 3.2.2.5
Cyclic ADP-ribose hydrolase 1
cADPr hydrolase 1
T10
CD38 antigen
Gene name
Name: CD38
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=2319135 [NCBI, ExPASy, EBI, Israel, Japan]
Jackson D.G., Bell J.I.;
"Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation.";
J. Immunol. 144:2811-2815(1990).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
TISSUE=Oesophageal carcinoma, and Pancreas;
DOI=10.1016/S0378-1119(96)00723-8; PubMed=9074508 [NCBI, ExPASy, EBI, Israel, Japan]
Nata K., Takamura T., Karasawa T., Kumagai T., Hashioka W., Tohgo A., Yonekura H., Takasawa S., Nakamura S., Okamoto H.;
"Human gene encoding CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase): organization, nucleotide sequence and alternative splicing.";
Gene 186:285-292(1997).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=B-cell;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[4]
SIMILARITY TO NADASE.
DOI=10.1016/0968-0004(92)90337-9; PubMed=1471258 [NCBI, ExPASy, EBI, Israel, Japan]
States D.J., Walseth T.F., Lee H.C.;
"Similarities in amino acid sequences of Aplysia ADP-ribosyl cyclase and human lymphocyte antigen CD38.";
Trends Biochem. Sci. 17:495-495(1992).
[5]
CHARACTERIZATION.
PubMed=8253715 [NCBI, ExPASy, EBI, Israel, Japan]
Takasawa S., Tohgo A., Noguchi N., Koguma T., Nata K., Sugimoto T., Yonekura H., Okamoto H.;
"Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP.";
J. Biol. Chem. 268:26052-26054(1993).
[6]
ACTIVE SITE.
PubMed=7961800 [NCBI, ExPASy, EBI, Israel, Japan]
Tohgo A., Takasawa S., Noguchi N., Koguma T., Nata K., Sugimoto T., Furuya Y., Yonekura H., Okamoto H.;
"Essential cysteine residues for cyclic ADP-ribose synthesis and hydrolysis by CD38.";
J. Biol. Chem. 269:28555-28557(1994).
[7]
SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
DOI=10.1186/gb-2004-5-2-r8; PubMed=14759258 [NCBI, ExPASy, EBI, Israel, Japan]
Hillman R.T., Green R.E., Brenner S.E.;
"An unappreciated role for RNA surveillance.";
Genome Biol. 5:RESEARCH008.1-RESEARCH008.16(2004).
[8]
X-RAY CRYSTALLOGRAPHY (1.91 ANGSTROMS) OF 45-300, AND DISULFIDE BONDS.
DOI=10.1016/j.str.2005.05.012; PubMed=16154090 [NCBI, ExPASy, EBI, Israel, Japan]
Liu Q., Kriksunov I.A., Graeff R., Munshi C., Lee H.C., Hao Q.;
"Crystal structure of human CD38 extracellular domain.";
Structure 13:1331-1339(2005).
[9]
VARIANT TRP-140.
DOI=10.1007/s001250051026; PubMed=9754820 [NCBI, ExPASy, EBI, Israel, Japan]
Yagui K., Shimada F., Mimura M., Hashimoto N., Suzuki Y., Tokuyama Y., Nata K., Tohgo A., Ikehata F., Takasawa S., Okamoto H., Makino H., Saito Y., Kanatsuka A.;
"A missense mutation in the CD38 gene, a novel factor for insulin secretion: association with Type II diabetes mellitus in Japanese subjects and evidence of abnormal function when expressed in vitro.";
Diabetologia 41:1024-1028(1998).
Comments
  • FUNCTION: Synthesizes cyclic ADP-ribose, a second messenger for glucose-induced insulin secretion. Also has cADPr hydrolase activity. Also moonlights as a receptor in cells of the immune system.
  • CATALYTIC ACTIVITY: NAD+ + H2O = ADP-ribose + nicotinamide.
  • ENZYME REGULATION: ATP inhibits the hydrolyzing activity.
  • SUBCELLULAR LOCATION: Membrane; Single-pass type II membrane protein.
  • ALTERNATIVE PRODUCTS: 2 named isoforms [FASTA] produced by alternative splicing.
    Name1
    Isoform IDP28907-1
    This is the isoform sequence displayed in this entry.
    Name2
    Isoform IDP28907-2
    Note: May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
    Features which should be applied to build the isoform sequence: VSP_000707, VSP_000708.
  • TISSUE SPECIFICITY: Expressed at high levels in pancreas, liver, kidney, brain, testis, ovary, placenta, malignant lymphoma and neuroblastoma.
  • DEVELOPMENTAL STAGE: Preferentially expressed at both early and late stages of the B and T-cell maturation. It is also detected on erythroid and myeloid progenitors in bone marrow, where the level of surface expression was shown to decrease during differentiation of blast-forming unit E to colony-forming unit E.
  • SIMILARITY: Belongs to the ADP-ribosyl cyclase family.
  • WEB RESOURCE: Name=Wikipedia; Note=CD38 entry; URL="http://en.wikipedia.org/wiki/CD38";.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
M34461; AAA68482.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
D84276; BAA18964.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
D84277; BAA18965.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
D84284; BAA18966.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC007964; AAH07964.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR A43521; A43521.
RefSeq NP_001766.2; -.
UniGene Hs.479214
3D structure databases
PDB
1YH3; X-ray; 1.91 A; A/B=45-300.[ExPASy / RCSB / EBI]
1ZVM; X-ray; 2.20 A; A/B/C/D=45-300.[ExPASy / RCSB / EBI]
2EF1; X-ray; 2.40 A; A/B=45-300.[ExPASy / RCSB / EBI]
2HCT; X-ray; 1.95 A; A/B=45-300.[ExPASy / RCSB / EBI]
2I65; X-ray; 1.90 A; A/B=45-300.[ExPASy / RCSB / EBI]
2I66; X-ray; 1.70 A; A/B=45-300.[ExPASy / RCSB / EBI]
2I67; X-ray; 1.71 A; A/B=45-300.[ExPASy / RCSB / EBI]
2O3Q; X-ray; 1.98 A; A/B=45-300.[ExPASy / RCSB / EBI]
2O3R; X-ray; 1.75 A; A/B=45-300.[ExPASy / RCSB / EBI]
2O3S; X-ray; 1.50 A; A/B=46-300.[ExPASy / RCSB / EBI]
2O3T; X-ray; 1.68 A; A/B=45-300.[ExPASy / RCSB / EBI]
2O3U; X-ray; 2.11 A; A/B=45-300.[ExPASy / RCSB / EBI]
2PGJ; X-ray; 1.71 A; A/B=45-300.[ExPASy / RCSB / EBI]
2PGL; X-ray; 1.76 A; A/B=45-300.[ExPASy / RCSB / EBI]
Detailed list of linked structures.
PDBsum 1YH3; -.
1ZVM; -.
2EF1; -.
2HCT; -.
2I65; -.
2I66; -.
2I67; -.
2O3Q; -.
2O3R; -.
2O3S; -.
2O3T; -.
2O3U; -.
2PGJ; -.
2PGL; -.
ModBase P28907.
Organism-specific databases
H-InvDB HIX0004112; -.
HIX0004113; -.
HGNC HGNC:1667; CD38.
GenAtlas CD38.
MIM 107270; gene. [NCBI / EBI]
PharmGKB PA26214; -.
GeneCards P28907.
Gene expression databases
ArrayExpress P28907; -.
CleanEx HS_CD38; -.
GermOnline ENSG00000004468; Homo sapiens.
Ontologies
GO
GO:0016021; Cellular component: integral to membrane (inferred from electronic annotation from UniProtKB-KW).
GO:0005624; Cellular component: membrane fraction (traceable author statement from ProtInc).
GO:0005886; Cellular component: plasma membrane (traceable author statement from ProtInc).
GO:0005488; Molecular function: binding (inferred from electronic annotation from InterPro).
GO:0003953; Molecular function: NAD+ nucleosidase activity (inferred from electronic annotation from InterPro).
GO:0004872; Molecular function: receptor activity (inferred from electronic annotation from UniProtKB-KW).
GO:0008624; Biological process: induction of apoptosis by extracellular signals (traceable author statement from ProtInc).
GO:0008152; Biological process: metabolic process (inferred from electronic annotation from InterPro).
GO:0007165; Biological process: signal transduction (non-traceable author statement from ProtInc).
QuickGo view.
Family and domain databases
InterPro IPR016040; NAD(P)-bd.
IPR003193; Rib_hydrolayse.
Graphical view of domain structure.
Gene3D G3DSA:3.40.50.720; NAD(P)-bd; 1.
PANTHER PTHR10912; Rib_hydrolayse; 1.
Pfam PF02267; Rib_hydrolayse; 1.
Pfam graphical view of domain structure.
BLOCKS P28907.
ProtoNet P28907.
Proteomic databases
PeptideAtlas P28907; -.
Genome annotation databases
Ensembl ENSG00000004468; Homo sapiens. [Contig view]
GeneID 952; -.
KEGG hsa:952; -.
NMPDR fig|9606.3.peg.23952; -.
Phylogenomic databases
HOGENOM P28907; -.
HOVERGEN P28907; -.
Other
NextBio 3962; -.
SOURCE CD38; Homo sapiens.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; Alternative splicing; Diabetes mellitus; Glycoprotein; Hydrolase; Membrane; NAD; Polymorphism; Receptor; Signal-anchor; Transmembrane.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom   To Length Description FTId
CHAIN   1   300  300     ADP-ribosyl cyclase 1. PRO_0000144066
TOPO_DOM   1    21  21     Cytoplasmic (Potential). 
TRANSMEM   22    42  21     Signal-anchor for type II membrane protein (Potential). 
TOPO_DOM   43   300  258     Extracellular (Potential). 
ACT_SITE   119   119         
ACT_SITE   201   201         
CARBOHYD   100   100        N-linked (GlcNAc...) (Potential). 
CARBOHYD   164   164        N-linked (GlcNAc...) (Potential). 
CARBOHYD   209   209        N-linked (GlcNAc...) (Potential). 
CARBOHYD   219   219        N-linked (GlcNAc...) (Potential). 
DISULFID   67    82         
DISULFID   99   180         
DISULFID   160   173         
DISULFID   254   275         
DISULFID   287   296         
VAR_SEQ   122   122        I -> K (in isoform 2). VSP_000707
VAR_SEQ   123   300        Missing (in isoform 2). VSP_000708
VARIANT   140   140  1     R -> W (seems to contribute to the development of type II diabetes; 50% reduction in activity; dbSNP:rs1800561 [NCBI]). VAR_001323 [3D]
MUTAGEN   119   119        C->K: Loss of cADPr hydrolase activity. 
MUTAGEN   119   119        C->R,E,A: Loss of cADPr hydrolase and ADP-ribosyl cyclase activity. 
MUTAGEN   160   160        C->A: Loss of cADPr hydrolase and ADP-ribosyl cyclase activity. 
MUTAGEN   173   173        C->A: Loss of cADPr hydrolase and ADP-ribosyl cyclase activity. 
MUTAGEN   201   201        C->D,K,A: Loss of cADPr hydrolase and ADP-ribosyl cyclase activity. 
MUTAGEN   201   201        C->E: Loss of cADPr hydrolase activity. 
CONFLICT   49    49        Q -> T (in Ref. 1; AAA68482). 
STRAND   49    53  5      
HELIX   59    73  15      
HELIX   75    77  3      
HELIX   82    91  10      
TURN   92    95  4      
HELIX   103   106  4      
HELIX   107   112  6      
HELIX   119   121  3      
STRAND   122   127  6      
HELIX   129   137  9      
HELIX   145   147  3      
HELIX   149   154  6      
STRAND   163   167  5      
STRAND   171   173  3      
TURN   176   179  4      
HELIX   184   199  16      
STRAND   202   209  8      
STRAND   212   216  5      
HELIX   221   224  4      
HELIX   226   228  3      
TURN   232   234  3      
STRAND   235   243  9      
HELIX   253   255  3      
HELIX   257   268  12      
STRAND   272   279  8      
HELIX   281   289  9      
Sequence information
Length: 300 AA [This is the length of the unprocessed precursor] Molecular weight: 34328 Da [This is the MW of the unprocessed precursor] CRC64: 47BBE38C3DE3E6AA [This is a checksum on the sequence]
        10         20         30         40         50         60 
MANCEFSPVS GDKPCCRLSR RAQLCLGVSI LVLILVVVLA VVVPRWRQQW SGPGTTKRFP 

        70         80         90        100        110        120 
ETVLARCVKY TEIHPEMRHV DCQSVWDAFK GAFISKHPCN ITEEDYQPLM KLGTQTVPCN 

       130        140        150        160        170        180 
KILLWSRIKD LAHQFTQVQR DMFTLEDTLL GYLADDLTWC GEFNTSKINY QSCPDWRKDC 

       190        200        210        220        230        240 
SNNPVSVFWK TVSRRFAEAA CDVVHVMLNG SRSKIFDKNS TFGSVEVHNL QPEKVQTLEA 

       250        260        270        280        290        300 
WVIHGGREDS RDLCQDPTIK ELESIISKRN IQFSCKNIYR PDKFLQCVKN PEDSSCTSEI 

P28907 in FASTA format

View entry in original UniProtKB/Swiss-Prot format
View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by au flag APAF Australia Mirror sites: Brazil  Canada  China  Korea  Switzerland
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!